Selitrectinib Uses, Dosage, Side Effects and more

Selitrectinib is under investigation in clinical trial NCT03215511 (Phase 1/2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusion Cancers).

Attribute	Details
Trade Name	Selitrectinib
Generic	Selitrectinib
Selitrectinib Other Names	Selitrectinib
Type
Formula	C20H21FN6O
Weight	Average: 380.427 Monoisotopic: 380.176087483
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph